A New Antiarrhythmic Drug in the Treatment of Recent-Onset Atrial Fibrillation: Vernakalant

被引:7
作者
Vizzardi, Enrico [1 ]
Salghetti, Francesca [1 ]
Bonadei, Ivano [1 ]
Gelsomino, Sandro [2 ]
Lorusso, Roberto [3 ]
D'Aloia, Antonio [1 ]
Curnis, Antonio [1 ]
机构
[1] Univ Brescia, Sect Cardiovasc Dis, Dept Expt & Appl Med, Brescia, Italy
[2] Careggi Hosp, Heart & Vessels Dept, Florence, SC USA
[3] Civ Hosp, Cardiac Surg Unit, Expt Cardiac Surg Lab, Brescia, Italy
关键词
Atrial fibrillation; Vernakalant; Cardioversion; RAPID CONVERSION; SINUS RHYTHM; EFFICACY; IBUTILIDE; SAFETY; FLUTTER; CARDIOVERSION; AMIODARONE; HYDROCHLORIDE; PROPAFENONE;
D O I
10.1111/1755-5922.12026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Summary Vernakalant is a new antiarrhythmic agent recently approved in Europe for the rapid cardioversion of recent-onset atrial fibrillation. It works by blocking early-activating K+ atrial channels and frequency-dependent atrial Na+ channels, prolonging atrial refractory periods and rate-dependent slowing atrial conduction, without promoting ventricular arrhythmia. Preclinical and clinical trials showed good toleration of this drug. The main purpose of our review is to describe all the trials that led to the incorporation of vernakalant into the current European atrial fibrillation guidelines.
引用
收藏
页码:e55 / e62
页数:8
相关论文
共 36 条
[1]   Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation [J].
Abi-Mansour, P ;
Carberry, PA ;
McCowan, RJ ;
Henthorn, RW ;
Dunn, GH ;
Perry, KT .
AMERICAN HEART JOURNAL, 1998, 136 (04) :632-642
[2]  
[Anonymous], CARD ANN SUSP ENR AC
[3]   Systematic Review and Meta-analysis of the Efficacy of Cardioversion by Vernakalant and Comparators in Patients with Atrial Fibrillation [J].
Bash, Lori D. ;
Buono, Jessica L. ;
Davies, Glenn M. ;
Martin, Amber ;
Fahrbach, Kyle ;
Phatak, Hemant ;
Avetisyan, Ruzan ;
Mwamburi, Mkaya .
CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (02) :167-179
[4]  
Beatch GN, 2003, CIRCULATION, V108, P85
[5]   Intravenous propafenone: Efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation - A single-blind placebo-controlled study [J].
Bellandi, F ;
Dabizzi, RP ;
Cantini, F ;
DiNatale, M ;
Niccoli, L .
CARDIOVASCULAR DRUGS AND THERAPY, 1996, 10 (02) :153-157
[6]   PROPAFENONE FOR CONVERSION OF RECENT-ONSET ATRIAL-FIBRILLATION - A CONTROLLED COMPARISON BETWEEN ORAL LOADING DOSE AND INTRAVENOUS ADMINISTRATION [J].
BORIANI, G ;
CAPUCCI, A ;
LENZI, T ;
SANGUINETTI, M ;
MAGNANI, B .
CHEST, 1995, 108 (02) :355-358
[7]   Efficacy and Safety of Vernakalant in Recent-Onset Atrial Fibrillation After the European Medicines Agency Approval: Systematic Review and Meta-Analysis [J].
Buccelletti, Francesco ;
Iacomini, Paolo ;
Botta, Gianfranco ;
Marsiliani, Davide ;
Carroccia, Annarita ;
Silveri, Nicolo Gentiloni ;
Franceschi, Francesco .
JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (12) :1872-1878
[8]   2012 focused update of the ESC Guidelines for the management of atrial fibrillation [J].
Camm, A. John ;
Lip, Gregory Y. H. ;
De Caterina, Raffaele ;
Savelieva, Irene ;
Atar, Dan ;
Hohnloser, Stefan H. ;
Hindricks, Gerhard ;
Kirchhof, Paulus ;
Bax, Jeroen J. ;
Baumgartner, Helmut ;
Ceconi, Claudio ;
Dean, Veronica ;
Deaton, Christi ;
Fagard, Robert ;
Funck-Brentano, Christian ;
Hasdai, David ;
Hoes, Arno ;
Knuuti, Juhani ;
Kolh, Philippe ;
McDonagh, Theresa ;
Moulin, Cyril ;
Popescu, Bogdan A. ;
Reiner, Zeljko ;
Sechtem, Udo ;
Sirnes, Per Anton ;
Tendera, Michal ;
Torbicki, Adam ;
Vahanian, Alec ;
Windecker, Stephan ;
Vardas, Panos ;
Al-Attar, Nawwar ;
Alfieri, Ottavio ;
Angelini, Annalisa ;
Blomstrom-Lundqvist, Carina ;
Colonna, Paolo ;
De Sutter, Johan ;
Ernst, Sabine ;
Goette, Andreas ;
Gorenek, Bulent ;
Hatala, Robert ;
Heidbuchel, Hein ;
Heldal, Magnus ;
Kristensen, Steen Dalby ;
Le Heuzey, Jean-Yves ;
Mavrakis, Hercules ;
Mont, Lluis ;
Filardi, Pasquale Perrone ;
Ponikowski, Piotr ;
Prendergast, Bernard ;
Rutten, Frans H. .
EUROPEAN HEART JOURNAL, 2012, 33 (21) :2719-2747
[9]   Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial [J].
Camm, A. John ;
Toft, Egon ;
Torp-Pedersen, Christian ;
Vijayaraman, Pugazhendhi ;
Juul-Moller, Steen ;
Ip, John ;
Beatch, Gregory N. ;
Dickinson, Garth ;
Wyse, D. George .
EUROPACE, 2012, 14 (06) :804-809
[10]   A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation [J].
Camm, A. John ;
Capucci, Alessandro ;
Hohnloser, Stefan H. ;
Torp-Pedersen, Christian ;
Van Gelder, Isabelle C. ;
Mangal, Brian ;
Beatch, Gregory .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (03) :313-321